Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
2
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
2
×
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
What
drug
2
×
new
2
×
advantages
bar
bio
brings
cholesterol
drugs
expect
expensive
faces
financial
foe
gamble
healthcare
hint
inhibitors
known
lowering
market
medco’s
mover
patients
payers
pcsk
physicians
plan
pricing
remember
roundup
sets
supposed
tough
type
ubiome
undone
vertex’s
wave
Language
unset
2
×
Current search:
drug
×
unset
×
" san francisco blog main "
×
new
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)